Database of All Patients Who Have Undergone Pulmonary Function Testing at Singapore General Hospital

Dyspnea Clinical Trial

Official title:

Prospective Database of All Patients Who Have Undergone Pulmonary Function Testing at Singapore General Hospital

Clinical Trial Details — Status: Completed

Administrative data

• NCT number: NCT01601288
• Other study ID #: 2011/845/Cpftdatabase
• Status: Completed
• Start date: May 2012
• Est. completion date: December 2017

Study information

• Verified date: May 2019
• Source: Singapore General Hospital
• Contact: n/a
• Is FDA regulated: No
• Study type: Observational

Clinical Trial Summary

The purpose of this study is to create a prospective database of all patients who have undergone pulmonary function testing from which the investigators can study the clinical phenotypes of various respiratory conditions. The investigators hope by understanding the differences in these myriad phenotypes to be able to provide individualized, patient-targeted therapy in the future.

Description:

Recent studies have shown that clinical phenotyping of patients with various respiratory conditions is important in the understanding of the disease process, clinical response to treatment, and prognosis. Pulmonary function testing is a very important aspect of clinical phenotyping in many respiratory conditions. Creating a database will enable us to study the various phenotypes within each respiratory condition. This will allow us to better understand each disease, with a view to provide personalized patient care targeted at their specific phenotype and hence better clinical outcomes.

Recruitment information / eligibility

• Status: Completed
• Enrollment: 17000
• Est. completion date: December 2017
• Est. primary completion date: December 2017
• Accepts healthy volunteers: No
• Gender: All
• Age group: 12 Years and older

Eligibility

Inclusion Criteria:

1) All patients who have undergone pulmonary function testing at the Singapore General Hospital pulmonary function laboratory

Related Conditions & MeSH terms

• Cough
• Dyspnea
• Lung Diseases
• Lung Diseases, Obstructive
• Obstructive Pulmonary Diseases
• Restrictive Lung Disease

Locations

Country	Name	City	State
Singapore	Singapore General Hospital	Singapore

Sponsors (1)

Lead Sponsor	Collaborator
Singapore General Hospital

Country where clinical trial is conducted

Singapore, 

References & Publications (2)

Nathan SD, Shlobin OA, Weir N, Ahmad S, Kaldjob JM, Battle E, Sheridan MJ, du Bois RM. Long-term course and prognosis of idiopathic pulmonary fibrosis in the new millennium. Chest. 2011 Jul;140(1):221-229. doi: 10.1378/chest.10-2572. Review. — View Citation

Nishimura M, Makita H, Nagai K, Konno S, Nasuhara Y, Hasegawa M, Shimizu K, Betsuyaku T, Ito YM, Fuke S, Igarashi T, Akiyama Y, Ogura S; Hokkaido COPD Cohort Study Investigators. Annual change in pulmonary function and clinical phenotype in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2012 Jan 1;185(1):44-52. doi: 10.1164/rccm.201106-0992OC. — View Citation

Outcome

Type	Measure	Description	Time frame	Safety issue
Primary	Diagnoses based on pulmonary function test interpretation	Interpretation of pulmonary function tests by a certified respiratory physician	7 days